Core Viewpoint - The AppLovin Corporation is facing a class action lawsuit for allegedly misleading investors regarding its advertising practices and financial performance during the specified class period from May 10, 2023, to February 25, 2025 [1][3]. Group 1: Allegations and Impact - The lawsuit claims that AppLovin created a false impression of its AXON 2.0 digital ad platform and AI technologies, suggesting they would enhance ad matching efficiency and expand into new markets [3]. - It is alleged that AppLovin engaged in manipulative practices, including exploiting advertising data from Meta Platforms and inflating installation numbers through a "backdoor installation scheme," which misrepresented its profit figures [3][4]. - Following the revelation of these practices on February 26, 2025, AppLovin's share price dropped by over 12% [4]. Group 2: Legal Process and Representation - Investors who purchased AppLovin securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [5]. - The lead plaintiff is typically the investor with the greatest financial interest and must be typical and adequate of the class [5]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud cases, having recovered $6.6 billion for investors in class action cases, significantly more than any other firm in recent years [6]. - The firm has a strong track record, including the largest securities class action recovery in history, amounting to $7.2 billion in the Enron case [6].

Core Viewpoint - A lawsuit has been filed against Viatris Inc. and certain senior executives for potential violations of federal securities laws, stemming from misleading statements regarding the company's operational status and the impact of a failed FDA inspection on its financial performance [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Western District of Pennsylvania, titled Quinn v. Viatris Inc., et al., No. 25-cv-466, with investors having until June 3, 2025, to seek lead plaintiff status [2]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Viatris securities [2]. Group 2: Company Background and Allegations - Viatris is a global healthcare company that provides medicines to approximately 1 billion patients across over 165 countries [3]. - The complaint claims that Viatris misrepresented the condition of its facilities, stating they were in "good operating condition" and suitable for their intended purposes, while downplaying the significance of a Warning Letter from the FDA following a failed inspection at its Indore, India facility [3][4]. Group 3: Financial Impact - The failed FDA inspection has had a substantial negative impact on Viatris's financial results, hindering the company from manufacturing and distributing key products, including Lenalidomide [4]. - Following the release of Q4 2024 results on February 27, 2025, Viatris disclosed that the inspection's repercussions would lower 2025 revenue by approximately $500 million and earnings from operations by about $385 million [5]. - The stock price of Viatris fell roughly 15% on February 27, 2025, dropping from $11.24 to $9.53 per share in response to the negative news [5].

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc. Investors have until June 10, 2025, to ask the Court to be ...

Core Viewpoint - A class action securities lawsuit has been filed against Ultra Clean Holdings, Inc. due to alleged securities fraud that affected investors between May 6, 2024, and February 24, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Ultra Clean misled investors about the demand for its products in the Chinese market, falsely reporting increased demand and revenue while concealing issues such as customer ramp problems and inventory corrections [2] - On February 24, 2025, Ultra Clean disclosed "demand softness" in China during its earnings call, leading to a significant stock price drop from $36.06 to $25.90, a decline of over 28% in one day [2] Group 2: Investor Information - Investors who suffered losses during the specified period have until May 23, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4]

The lawsuit seeks to provide restitution for BigBear.ai Holdings investors who were adversely affected due to alleged securities fraud in the specified period. Affected investors have until June 10, 2025 to request that the Court appoint them as the lead plaintiff. Investors Who Suffered Losses Are Encouraged to Contact Wolf Haldenstein NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP, the prominent law firm, informs investors that a lawsuit has been filed to recover lo ...

Core Viewpoint - A class action securities lawsuit has been filed against Ultra Clean Holdings, Inc. due to alleged securities fraud that affected investors between May 6, 2024, and February 24, 2025 [1][2]. Group 1: Allegations and Company Performance - The lawsuit claims that Ultra Clean misled investors about the demand for its products in the Chinese market, stating that demand was high and revenue was doubling, while concealing issues such as customer ramp problems and inventory corrections [2]. - On February 24, 2025, Ultra Clean reported its fourth quarter and full year 2024 results, revealing "demand softness" in China, which led to a significant drop in stock price from $36.06 to $25.90, a decline of over 28% in one day [2]. Group 2: Legal Proceedings and Investor Information - Investors who suffered losses during the specified timeframe have until May 23, 2025, to request to be appointed as lead plaintiff in the lawsuit, although participation does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating a no-cost participation in the lawsuit [3]. Group 3: Law Firm Background - Levi & Korsinsky, the law firm handling the case, has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top firms in the United States [4].

NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Ready Capital Corporation (NYSE: RC) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Ready Capital, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/ready-capital-corporation. Investors have until May 5, 2025, to ask the Court to ...

NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or the "Company") (NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Teleflex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. Attorney advertising. Prior results do not guarantee similar outcomes. C ...

Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle Peyton Pomerantz LLP dpeyton@pomlaw.com 646-581-9980 ext. 7980 Following publication of the report, XP's stock price fell $0.82 per share, or 5.48%, to close at $14.14 per share on March 12, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late ...